EU lists rare nerve disorder as possible side-effect of AstraZeneca vaccine

23 Sept 03:42 Key points summarised by AI

Europe's medicines regulator has identified Guillain-Barré syndrome (GBS), an extremely rare nerve-damaging disorder, as a possible side-effect of AstraZeneca's COVID-19 vaccine.
Categorized as "very rare" with a "reasonable possibility" of a causal link, the European Medicines Agency (EMA) emphasizes that the vaccine's benefits continue to outweigh its risks.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.